Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
11/24/2004 | CN1549730A Compositions and methods of using capsid protein from flaviviruses and pestiviruses |
11/24/2004 | CN1549717A Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity, process for producing them and pharmaceutical compositions containing them |
11/24/2004 | CN1549714A Aminoisoxazole derivatives active as kinase inhibitors |
11/24/2004 | CN1549713A Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof |
11/24/2004 | CN1549705A Extended release oral dosage form |
11/24/2004 | CN1548436A Novel 2-alkyl substituted imidazole compounds |
11/24/2004 | CN1548434A Benzothiophene compounds and their prepn and medicine use |
11/24/2004 | CN1548432A Stabilizing method and medicine composition of catechin monomer |
11/24/2004 | CN1548421A Tilmisartan salt and its prepn |
11/24/2004 | CN1548130A Medicine for treating coronary heart disease and angina pectoris and its pharmacologic effect |
11/24/2004 | CN1548119A Yiqingwan bolus and its prepn |
11/24/2004 | CN1548077A Chinese medicine prepn for treating coronary heart disease and rheumatic heart disease |
11/24/2004 | CN1548076A Liquid composition prepn of magnesium salt and blood circulation promoting and blood clots dispersing Chinese medicine |
11/24/2004 | CN1548061A Mongolia medicine for treating coronary heart disease and angina pectoris |
11/24/2004 | CN1548058A Prepn process of alive adult roach extract |
11/24/2004 | CN1548047A Cyclovirobuxine dripping pill and its prepn. process |
11/24/2004 | CN1548046A Baicalin-zinc medicine |
11/24/2004 | CN1548039A Red sage dripping pill and its prepn |
11/24/2004 | CN1177039C Bacillus adhaerens and its use in preparing health food having thrombolysis property |
11/24/2004 | CN1176941C Caspase inhibitors and the use thereof |
11/24/2004 | CN1176932C Zinc fructose-diphosphate and its preparing process and application |
11/24/2004 | CN1176922C 8-quinolinxanthine and 8-isoquinolinxanthine derivs. as PDE 5 inhibitors |
11/24/2004 | CN1176916C Semi-synthetic taxanes with antitumor and antiangiogenetic activities |
11/24/2004 | CN1176911C Benzidine-sulfuryl radical substitution pentatomic heterocycle, its preparation method, its medicinal and composition |
11/24/2004 | CN1176909C Uses of thaliporphine or its derivatives in treatment of cardiac diseases and preparation of same |
11/24/2004 | CN1176903C Method for synthesis of N-[(S)-1-carboxybutyl]-(S)-alanine esters and use in synthesis of perindoprill |
11/24/2004 | CN1176716C Composition for prevention and/or treatment of atheromatous arteriosclerosis |
11/24/2004 | CN1176711C Dampness-removing embolism-dissolving medicinal liquor |
11/24/2004 | CN1176709C Drug for curing scald, wound as well as hemorrhoids |
11/24/2004 | CN1176707C Guttate pills for treating obstruction of qi in the chest and chest pain and preparing process thereof |
11/24/2004 | CN1176696C Process for preparing Chinese medicine for treating hyperlipemia, hypertension and arteriosclerosis |
11/24/2004 | CN1176685C Medicine for preventing and treating coronary heart disease and its prepn process |
11/24/2004 | CN1176677C Chinese medicine composition for treating cardiovascular and cerebrovascular diseases and its preparing process |
11/24/2004 | CN1176674C Rehmannia root extract and its preparing process and application |
11/24/2004 | CN1176670C Active animal protein liquid and its application |
11/24/2004 | CN1176660C Pharmaceutical application of froctose biphosphate magnesium |
11/24/2004 | CN1176658C Aseptic freeze-dried prostaglandin injection and its preparing method and use |
11/24/2004 | CN1176656C Freeze-drying composition for injection |
11/24/2004 | CN1176648C Hawthorn leaves total flavone soft capsule and its preparing method |
11/23/2004 | US6822141 Diacylglycerol acyl transferase proteins |
11/23/2004 | US6822120 Sulfone liver X-receptor modulators |
11/23/2004 | US6822112 Prostaglandin derivatives |
11/23/2004 | US6822100 Reacting n-sulfonyl-3-vinylindole with ruthenium complex in presence of ethyl diazoacetate and toluene; psychological, sexual, and eating disorders |
11/23/2004 | US6822099 Method of resolving amlodipine racemate |
11/23/2004 | US6822097 Compounds and methods of uses |
11/23/2004 | US6821987 4-substituted by azolylureido-phenoxy, or phenylthio; antitumor agents; treating diabetic retinopathy, chronic rheumatism, psoriasis, atherosclerosis, |
11/23/2004 | US6821986 Drugs such as (2s)-2-amino-n-(4-anilinophenyl)-5-((imino(2-oxido-2 -oxohydrazino)methyl)amino) pentanamide, used as nitric oxide synthase inhibitors, free radical scavangers or as antioxidants |
11/23/2004 | US6821985 Administering an nr2b subtype selective n-methyl-d-aspartate (nmda) receptor antagonist with a thrombolytic agent for treating hypoxic or ischemic stroke |
11/23/2004 | US6821984 Ring fused pyrazole derivatives as CRF antagonists |
11/23/2004 | US6821978 Xanthine phosphodiesterase V inhibitors |
11/23/2004 | US6821977 Antidiabetic agents |
11/23/2004 | US6821974 Vasodilation; hypotensive agents; cardiovascular disorders |
11/23/2004 | US6821973 Compounds |
11/23/2004 | US6821971 For prophyalxis of rheumatoid arthritis, osteoarthritis, inflammatory bowel disease (ibs), septic shock, cardiopulmonary dysfunction, acute respiratory disease, cachexia |
11/23/2004 | US6821970 Useful for treating diseases wherein modulation of 5-ht activity is desired; nervous system disorders |
11/23/2004 | US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia |
11/23/2004 | US6821966 Antiinflammatory agents |
11/23/2004 | US6821965 Important in disease or medical conditions such as inflammation and immunoregulation |
11/23/2004 | US6821964 For prophylaxis and therapy of diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation |
11/23/2004 | US6821962 Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and /or p56lck tyrosine kinases |
11/23/2004 | US6821956 Oligodeoxynucleotide decoys for the prophylactic or therapeutic treatment of diseases associated with the binding of endogenous transcription factors to genes involved in cell growth, differentiation and signalling or to viral genes. |
11/23/2004 | US6821950 Antagonist of a g protein-coupled receptor, which has no agonist activity, and which has a cyclic or constrained acyclic structure |
11/23/2004 | US6821394 Process of extracting from haw-pit by dry distillation and its device |
11/23/2004 | CA2329788C Quinoline derivatives |
11/23/2004 | CA2326970C Acetylene derivatives as anti-inflammatory/analgesic agents |
11/23/2004 | CA2161346C Sulfonamides and derivatives thereof that modulate the activity of endothelin |
11/23/2004 | CA2135768C Indolocarbazole imides and the use thereof |
11/23/2004 | CA2125288C Serotoninergic ergoline derivatives |
11/23/2004 | CA2111662C Biphenyl derivatives, their preparation and their use for the treatment of hypertension and cardiac disease |
11/18/2004 | WO2004099394A2 A method for efficient transfer of human blastocyst-derived stem cells (hbs cells) from a feeder-supported to a feeder-free culture system |
11/18/2004 | WO2004099180A1 Novel piperidine derivatives |
11/18/2004 | WO2004099179A1 Piperazine-alkyl-ureido derivatives |
11/18/2004 | WO2004099176A1 Derivatives of piperidinyl- and piperazinyl-alkyl carbamates, preparation methods thereof and application of same in therapeutics |
11/18/2004 | WO2004099137A1 Aminocyclohexyl ether compounds and uses thereof |
11/18/2004 | WO2004099133A1 2”-hydroxynicotianamine, process for producing the same and angiotensin converting enzyme inhibitor, hypotensive drug and health food |
11/18/2004 | WO2004098713A2 Treating cardiovascular diseases with a compound of formula (i) (cs 747 - prasugrel; rn 150322-43-4) |
11/18/2004 | WO2004098638A1 Effector cell function inhibitor |
11/18/2004 | WO2004098634A2 Protein arginine n-methyltransferase 2 (prmt-2) |
11/18/2004 | WO2004098623A1 A notoginseng saponin intravenous injection and the method for preparing this injection |
11/18/2004 | WO2004098611A1 Fortifier |
11/18/2004 | WO2004098604A1 Therapeutic agents comprising an anti-angiogenic agent in combination with an src-inhibitor and their therapeutic use |
11/18/2004 | WO2004098525A2 Uses of ion channel modulating compounds |
11/18/2004 | WO2004098499A2 Hematopoietic stem cells and methods of treatment of neovascular eye diseases therewith |
11/18/2004 | WO2004082582A3 Use of diazoxide in the treatment of ischemia retinae |
11/18/2004 | WO2004082573A3 Diagnostics and therapeutics for diseases associated with dopamine receptor d4 (drd4) |
11/18/2004 | WO2004073613A3 A medicine and food |
11/18/2004 | WO2004073593A3 Use of acylated aminopropanediols and sulphur and nitrogen analogues of same for different therapeutic applications |
11/18/2004 | WO2004071381A3 Drugs containing substituted 2-aryl-aminoacetic acid compounds and/or substituted 2-heteroaryl-aminoacetic acid compounds |
11/18/2004 | WO2004062686A3 Therapeutic use of modulators of notch |
11/18/2004 | WO2004038406A3 Diagnostics and therapeutics for diseases associated with human g protein-coupled receptor 42 (gpr42) |
11/18/2004 | WO2004002528A9 Compositions and methods for therapeutic treatment |
11/18/2004 | WO2003038043A3 Combinations of dr5 antibody and other therapeutic agents |
11/18/2004 | WO2003037913A3 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
11/18/2004 | WO2002086087A3 Cytokine protein family |
11/18/2004 | US20040231005 Comprises proteolytic enzymes for use as tools to identify modulators for treatment and prevention of gastrointestinal, cell proliferative and inflammatory diseases |
11/18/2004 | US20040230064 Novel labeled resiniferatoxin derivatives |
11/18/2004 | US20040229957 cholesterol ester transfer protein inhibitors, new type of a preventive or therapeutic agent for atherosclerosis or hyperlipidemia |
11/18/2004 | US20040229946 Antidiabetic agents |
11/18/2004 | US20040229945 use in inhibiting angiogenesis in a mammal |
11/18/2004 | US20040229933 Treatment of hypertension |